Post-treatment monitoring in cancer care is essential for identifying recurrence and managing the long-term health of survivors. After the completion of primary cancer treatment, patients are at risk of both recurrence of the original cancer and the development of secondary cancers. Regular surveillance through imaging tests, blood work, and physical exams helps detect any signs of recurrence early, improving the chances for effective intervention. For some cancers, genetic markers and specific molecular tests are employed to monitor for recurrence or the emergence of treatment-resistant mutations. Additionally, long-term monitoring also includes addressing the psychological and emotional impact of survivorship, as patients may face anxiety about recurrence. The integration of personalized monitoring strategies, based on the type and stage of cancer, offers a more tailored and proactive approach to survivorship care, significantly improving overall outcomes and quality of life for cancer survivors.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States